Posts Tagged ‘FDA’

Year
Month
Category
Clear Filters
Egg

Panera Wants FDA to Crack Down on Eggs

January 28, 2018

Consumer Trends, Health & Obesity, Health Policy

Panera want you to know that they will sell you a better egg sandwich than anyone else. This is a natural extension of their smug advertising that tells us they sell “food as it should be.” So now, they’d like a little help from FDA. They want the agency to crack down on fast food […]

Read More
Ozempic (semaglutide) Injection Pen

Semaglutide Approved for Type 2 Diabetes

December 6, 2017

Health & Obesity

Late yesterday, a new, once-weekly injection for type 2 diabetes cleared the hurdle of FDA approval for sale. Semaglutide, will be available early next year in a familiar pen injection device. It will come in two doses: 0.5 and 1.0 mg once weekly. For people with type 2 diabetes it’s great to have a once-weekly […]

Read More
Young Tobacco

Guest Post: Where Is FDA Going with Nicotine and Tobacco?

November 14, 2017

Health & Obesity, Health Policy

At the end of July, FDA Commissioner, Scott Gottlieb, and his Center for Tobacco Products (CTP) Director, Mitch Zeller, announced a commitment and vision to dramatically change the impact of tobacco in the US. To understand how far-reaching this plan is, consider the following basics on the state of nicotine policy and science. 1. As a result of […]

Read More
Waiting

Nutrition Facts Labels: Delay, Delay, Delay

October 2, 2017

Health & Obesity, Health Policy

Almost five years. That’s how long most businesses can wait before they tell consumers how much sugar they’re adding to food products. The FDA announced Friday that they were adding another year and a half to the original deadlines announced in 2016 when Michelle Obama unveiled updated Nutrition Facts labels. Companies with less than $10 […]

Read More
Queen City of the Gold Rush

Boon or Bane? The FDA Cardiovascular Safety Hurdle

July 29, 2017

Health & Obesity, Health Policy, Scientific Meetings & Publications

Almost ten years ago, FDA set a new hurdle for approving new diabetes drugs. Before one of these new drugs could be approved, the sponsoring company would need an expensive cardiovascular safety study. How expensive? The price tag might run as high as a billion dollars. FDA laid this same requirement on new obesity drugs, […]

Read More

Delaying, Not Dropping, the Nutrition Facts Label Update

June 24, 2017

Health & Obesity, Health Policy

A few weeks ago, the FDA announced an indefinite delay in the new Nutrition Facts label. This label discloses what’s in every food product sold in the U.S. It would — for the first time ever — give consumers information about how much added sugar is in a product. Howls of Protest When this delay surfaced, howls […]

Read More
Organic Architecture

A Stent for Obesity Progressing into Larger Trials

May 1, 2017

Health & Obesity, Scientific Meetings & Publications

Making progress with medical devices to treat obesity is a tedious business. And it comes with many ups and downs. But with a more reasonable pathway for FDA approvals these days, more entrepreneurs are trying to advance their ideas. In the latests news, the folks developing a hunger-curbing stent for obesity have raised $2.1 million […]

Read More
Confused Rope

Health Claims Handy for Confusing Consumers

April 30, 2017

Health & Obesity, Health Policy, Scientific Meetings & Publications

What does it mean when a food label says the product is healthy? For the last six months, more than a thousand public comments have poured into FDA. Two answers rise to the top. Health claims on a food label seem to be good for a bump in sales and for confusing consumers. Peculiar Advice […]

Read More
Climbing the Dunes

A Steady Climb in Obesity or a Blockbuster Breakthrough?

April 29, 2017

Health & Obesity

Making progress in obesity care continues to be a slow and steady business. Nearly 100 million Americans have this complex chronic disease. But it’s so stigmatized that most people don’t really want to think about it – let alone seek care. But progress continues, with a steady climb on all fronts. News from Novo Nordisk – now […]

Read More
Slow Motion

Really? FDA Should Slow Down?

April 8, 2017

ConscienHealth, Health & Obesity, Health Policy

Here’s a news flash you don’t see every day. Industry says FDA should slow down. Usually drug and medical device companies are complaining that the agency doesn’t move fast enough. Food companies now are saying that FDA shouldn’t move so fast on requiring new and improved nutrition labels on food products. FDA Commissioner Nominee “Delighted” to Consider Slowing […]

Read More

©2009-2026 ConscienHealth. All rights reserved. | Website Design by Mariela Antunes | Hosting by DTS